|
|
Thanyaphong Na Nakorn, David Traver, Irving L. Weissman, Koichi Akashi
J Clin Invest. 2002;
109(12):1579
doi:10.1172/JCI15272
Abstract |
Full text
| PDF

W
hole-body irradiation at the minimal lethal dose causes bone marrow failure and death within 12–18 days. To identify the principal components of the hematopoietic system that are radioprotective, we transplanted lethally irradiated mice with purified progenitors: common myeloid progenitors (CMPs), megakaryocyte/erythrocyte-restricted progenitors (MEPs), or granulocyte/monocyte-restricted progenitors (GMPs). Transplanted CMPs gave rise to cells both of the granulocyte/monocyte (GM) series and the megakaryocyte/erythrocyte series, whereas GMPs or MEPs showed reconstitution of only GM or ME cells, respectively. CMPs and MEPs but not GMPs protected mice in a dose-dependent manner, suggesting that erythrocytes, platelets, or both are the critical effectors of radioprotection. Accordingly, CMPs and MEPs formed robust colonies in recipient bone marrow and spleen, whereas GMPs formed small colonies that rapidly disappeared. Direct comparisons of spleen CFU (CFU-S) potentials among each progenitor subset showed that MEPs contain the vast majority of day 8 CFU-S activity, suggesting that day 8 CFU-S are the precursors of radioprotective cell subsets. All animals radioprotected for 30 days subsequently survived for at least 6 months post-transplant, and showed only host-derived hematopoiesis after 30 days. These findings suggest that rare hematopoietic stem cells survive myeloablation that can eventually repopulate irradiated hosts if myeloerythroid-restricted progenitors transiently rescue ablated animals through the critical window of bone marrow failure.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(29)
| Title and authors |
Publication |
Year |
Crosstalk between NOTCH and AKT signaling during murine megakaryocyte lineage specification
M. G. Cornejo, V. Mabialah, S. M. Sykes, T. Khandan, C. Lo Celso, C. K. Lopez, P. Rivera-Munoz, P. Rameau, Z. Tothova, J. C. Aster, R. A. DePinho, D. T. Scadden, D. G. Gilliland, T. Mercher
|
Blood
|
2011 |
Deletion of proapoptotic Puma selectively protects hematopoietic stem and progenitor cells against high-dose radiation.
Lijian Shao, Yan Sun, Zhonghui Zhang, Wei Feng, Yongxing Gao, Zailong Cai, Zack Z Wang, A Thomas Look, Wen-Shu Wu
|
Blood
|
2010 |
Deletion of Puma protects hematopoietic stem cells and confers long-term survival in response to high-dose gamma-irradiation.
Hui Yu, Hongmei Shen, Youzhong Yuan, Richard XuFeng, Xiaoxia Hu, Sean P Garrison, Lin Zhang, Jian Yu, Gerard P Zambetti, Tao Cheng
|
Blood
|
2010 |
Graft source determines human hematopoietic progenitor distribution pattern within the CD34+ compartment
C Arber, J Halter, M Stern, A Rovó, A Gratwohl, A Tichelli
|
Bone Marrow Transplant
|
2010 |
A major role of TGF- 1 in the homing capacities of murine hematopoietic stem cell/progenitors
C. Capron, C. Lacout, Y. Lecluse, V. Jalbert, H. Chagraoui, S. Charrier, A. Galy, A. Bennaceur-Griscelli, E. Cramer-Borde, W. Vainchenker
|
Blood
|
2010 |
The Inherent Differentiation Program of Short-Term Hematopoietic Repopulating Cells Changes During Human Ontogeny
Marlene Tacke, Claudia R. Ball, Manfred Schmidt, Silke Klingenberg, Birgitta Maurer, Sylvia Fessler, Connie J. Eaves, Christof von Kalle, Hanno Glimm
|
Stem Cells and Development
|
2010 |
In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells.
Benjamin J Frisch, Rebecca L Porter, Benjamin J Gigliotti, Adam J Olm-Shipman, Jonathan M Weber, Regis J O'Keefe, Craig T Jordan, Laura M Calvi
|
Blood
|
2009 |
Amelioration of murine beta-thalassemia through drug selection of hematopoietic stem cells transduced with a lentiviral vector encoding both gamma-globin and the MGMT drug-resistance gene.
Huifen Zhao, Tamara I Pestina, Md Nasimuzzaman, Perdeep Mehta, Phillip W Hargrove, Derek A Persons
|
Blood
|
2009 |
Treatment of mice with the Ah receptor agonist and human carcinogen dioxin results in altered numbers and function of hematopoietic stem cells.
Kameshwar P Singh, Amber Wyman, Fanny L Casado, Russell W Garrett, Thomas A Gasiewicz
|
Carcinogenesis
|
2009 |
MLL5 contributes to hematopoietic stem cell fitness and homeostasis.
Yan Zhang, Jasmine Wong, Mark Klinger, Mary T Tran, Kevin M Shannon, Nigel Killeen
|
Blood
|
2009 |
|